🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been granted for transformative findings that illuminate how the body's defense network targets dangerous infections while sparing the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this honor.

Their work identified specialized "sentinels" within the defense system that remove rogue immune cells capable of attacking the body.

These discoveries are now paving the way for new treatments for immune disorders and malignancies.

These winners will share a monetary award valued at 11 million SEK.

Crucial Discoveries

"Their work has been essential for comprehending how the body's defenses functions and why we do not all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

The team's studies explain a core mystery: How does the immune system defend us from numerous invaders while leaving our own tissues intact?

The body's protection system uses immune cells that search for signs of infection, even pathogens and germs it has never encountered.

These defenders employ sensors—known as recognition units—that are generated randomly in countless combinations.

This provides the defense network the ability to combat a wide array of invaders, but the randomness of the process unavoidably produces white blood cells that can target the host.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic defense cells were destroyed in the thymus—where immune cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to disarm other defenders that assault the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.

A prize committee stated, "These discoveries have established a novel area of investigation and accelerated the creation of new therapies, for example for cancer and immune disorders."

Regarding cancer, T-regs prevent the system from fighting the growth, so research are aimed at lowering their quantity.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the body is not being harmed. A comparable approach could also be effective in minimizing the chances of organ transplant rejection.

Innovative Studies

Prof Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their thymus extracted, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from other mice could prevent the disease—suggesting there was a system for blocking defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and people that led to the discovery of a gene vital for the way T-regs operate.

"The groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from accidentally targeting the healthy cells," said a prominent biological science specialist.

"This research is a remarkable example of how basic biological research can have far-reaching consequences for public health."